National supported research with China

In 2013 the Swedish Research Council (Vetenskapsrådet) launched two calls for research collaborations with China.

The Karolinska-China-Hong Kong Regenerative Medicine Initiative

KI researcher Ken Chien was awarded one of the four, highly competitive, grants for The Karolinska-China-Hong Kong Regenerative Medicine Initiative. The grant is 4 800 000 per year for five years.

Read more about Ken Chien's research group at the Department of Medicine Huddinge and Ken Chien's research group at the Department of Cell and Molecular Biology

Framework grant in antimicrobial resistance, Sweden-NSFC (China) joint research program

The second call was funded jointly by the Swedish Research Council and the Natural Science Foundation, China and was called "Framework grant in antimicrobial resistance, Sweden-NSFC (China) joint research program”.

KI was awarded two of these grants (5 000 000 a year for five years):

  1. Novel natural compounds that target the cell wall (and other components) of bacteria: generation of basic knowledge, new tools and potential drugs candidates, Birgitta Henriques Normark. 
    Read more about Birgitta Henriques Normark's research group.
  2. Epidemiology, risk factors and transmission mechanisms of the emergence of multidrug and extensively drug resistant tuberculosis, Sven Hoffner.
    Read more about Sven Hoffner's research group.

The Framework grant in antimicrobial resistance, Sweden-NSFC (China) joint research program

Public Health Agency of Sweden

In addition to the two above mentioned grants, KI researchers are involved in a a project from the Public Health Agency of Sweden that was awarded a grant:

  • IMPACT - Svensk-Kinesiskt tvärsektoriellt samarbete för begränsning av antibiotikaresistens (Swedish-Chinese cross-sectoral cooperation for limiting antibiotic resistance), PI Otto Cars, Uppsala university, and KI-collaborators Göran Tomson/Cecilia Stålsby-Lundborg.
     

Links

Collaboration